Tunisian-Swiss round table on innovation in pharmaceutical industry | Tunisia News Gazette

Tunisian-Swiss round table on innovation in pharmaceutical industry

The development of the pharmaceutical sector in Tunisia requires the achievement of several objectives by 2020, including the development of 1,100 clinical studies, said Anis Klouz, director of medical research at the Ministry of Health.

Speaking at a round table organised on Thursday in Tunis at the initiative of the Swiss Embassy, on the theme “the forces of public-private dialogue to guide innovation: the example of Tunisian cooperation in the field of clinical research”, he said that the aim is, also, to make sure to attract 35% of clinical trials conducted in Africa to Tunisia.

“These clinical trials will enable nearly 55,000 patients to benefit from the best therapeutic choices and generate 600 new skilled jobs,” he said.

The pharmaceutical industry’s role is to ensure the safety of the country, he added, confirming that the ultimate goal is to develop our own industry in Tunisia.

“We currently have a 50% coverage rate for our drug needs, compared to 8% in the 1990s,” he said.

For his part, Dr. Yosra Kerken, medical director at the Swiss company Roche in Tunisia, emphasised the importance of innovation, highlighting its role in proposing new solutions for treating patients.

Conducting clinical studies will save the lives of patients by providing them with the best possible medicines, “she said, while Nicola Yuste, Public Relations Manager for Novartis Switzerland, presented the programme the Swiss experience in the pharmaceutical industry, stating that several factors have contributed to its success.

Swiss ambassador to Tunisia, Rita Adam pointed out that Switzerland is ranked 14th country investor in Tunisia. “The goal of Switzerland is to contribute to the improvement of the conditions of investment in Tunisia, to strengthen the cultural and scientific exchange between the two countries,” she said, announcing the intention to establish a Tunisian-Swiss cultural fund.

The public-private dialogue in the field of medicines, conducted from 2014 to 2017 by the Ministry of Health and the pharmaceutical industry with the support of the World Bank, aimed at reforming a growing sector of the Tunisian economy and improving the framework conditions to promote its development and strengthen its competitiveness.

In particular, it has led to draft decrees aimed at shortening the time required for marketing authorisation and simplifying the procedures for setting the price of imported medicines.

Several Swiss companies established in Tunisia participated in this dialogue and contributed to its results by sharing their experience and expertise in terms of innovation and public-private partnership.

Source: TAP News Agency

Civil society activists underlined the need to tackle political violence against women in election campaigns
Civil society activists underlined the need to tackle political violence against women in election campaigns
TUNISAIR had just launched its new Android mobile application TUNISAIR Apps, through which the customer
Solar and wind energy should be prioritised in Tunisia's energy policies to achieve an energy
Information Minister Melhem Riachy said that he plans to modernize the Ministry of Information and